期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
中药注射剂致敏成分群筛查方法研究的现状与免疫综合法 被引量:18
1
作者 贺福元 邓凯文 +4 位作者 曾姣丽 戴儒文 夏赞韶 刘文龙 石继连 《中国中药杂志》 CAS CSCD 北大核心 2012年第19期2836-2841,共6页
中药注射剂在我国已有60多年的发展及应用历程,近些年来不良反应的报道层出不穷。筛查中药注射剂的致敏成分群(致敏原群)的研究为世人关注,已成为国际性难题。该文先根据其产生免疫毒性的机制,分析中药注射剂致敏原筛查技术研究的现状,... 中药注射剂在我国已有60多年的发展及应用历程,近些年来不良反应的报道层出不穷。筛查中药注射剂的致敏成分群(致敏原群)的研究为世人关注,已成为国际性难题。该文先根据其产生免疫毒性的机制,分析中药注射剂致敏原筛查技术研究的现状,然后提出采用免疫底、盖芯片及免疫指纹图谱相结合的免疫综合分析筛查中药注射剂致敏成分群,旨在为中药注射剂的研制与临床使用构筑安全性评价屏障。 展开更多
关键词 中药注射剂 免疫毒性 致敏原 类致敏原 免疫芯片 免疫指纹图 免疫综合法
原文传递
Need for a comprehensive medical approach to the neuroimmuno-gastroenterology of irritable bowel syndrome 被引量:14
2
作者 Pejman Katiraei Gilberto Bultron 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第23期2791-2800,共10页
Irritable bowel syndrome (IBS) is defined by the Rome ]I[ criteria as symptoms of recurrent abdominal pain or discomfort with the onset of a marked change in bowel habits with no evidence of an inflammatory, anatomi... Irritable bowel syndrome (IBS) is defined by the Rome ]I[ criteria as symptoms of recurrent abdominal pain or discomfort with the onset of a marked change in bowel habits with no evidence of an inflammatory, anatomic, metabolic, or neoplastic process. As such, many clinicians regard IBS as a central nervous system problem of altered pain perception. Here, we review the recent literature and discuss the evidence that supports an organic based model, which views IBS as a complex, heterogeneous, inter-dependent, and multi-variable inflammatory process along the neuronal-gut axis. We delineate the organic pathophysiology of IBS, demonstrate the role of inflammation in IBS, review the possible differences between adult and pediatric IBS, discuss the merits of a comprehensive treatment model as taught by the Institute of Functional Medicine, and describe the potential for future research for this syndrome. 展开更多
关键词 Irritable bowel syndrome Abdominal pain INFLAMMATION PROBIOTICS Stress
下载PDF
Simplified microsatellite instability detection protocol provides equivalent sensitivity to robust detection strategies in Lynch syndrome patients 被引量:4
3
作者 Hadi Babaei Mehrdad Zeinalian +3 位作者 Mohammad Hassan Emami Mortaza Hashemzadeh Najmeh Farahani Rasoul Salehi 《Cancer Biology & Medicine》 SCIE CAS CSCD 2017年第2期142-150,共9页
Objective:Germline mutations in mismatch repair(MMR)genes cause Lynch syndrome(LS).LS is an inherited disease,and an important consequence of MMR deficiency is microsatellite instability(MSI)phenotype.MSI phenotype in... Objective:Germline mutations in mismatch repair(MMR)genes cause Lynch syndrome(LS).LS is an inherited disease,and an important consequence of MMR deficiency is microsatellite instability(MSI)phenotype.MSI phenotype influences the efficacy of5 fluorouracil(5-FU)chemotherapy.Reproducible,cost effective,and easy to perform laboratory tests are required to include MSI detection in routine laboratory practice.Evaluation of CAT25 as monomorphic short tandem repeat sequence enables CAT25 to be an efficient screening tool among hereditary nonpolyposis colorectal cancer(HNPCC)patients compared with other methods used currently.Methods:Based on Amsterdam II criteria,31 patients in 31 families were shortlisted from a total number of 1,659 colorectal cancer patients.MSI status was examined in these patients using CAT25 and a commercially available Promega MSI five-markerbased detection system as well as immunohistochemical(IHC)staining of four important MMR proteins.Patients were scored as high microsatellite instable(MSI-H),low(MSI-L),or stable(MSS).MSI status determined by CAT25 single mononucleotide marker was compared with that of five mononucleotide markers,Promega commercial kit,and IHC method.Results:MMR protein deficiency was observed on 7/31 probands using IHC methodology and 6/31 categorized as MSI-H using commercial kit or CAT25 single marker.The sensitivity and specificity of the CAT25 single marker were the same as those detected by five-marker Promega commercial kit in our patients.Conclusions:Based on our results,the performance of the CAT25 single mononucleotide marker for MSI status determination in our HNPCC patients is the same as that of the five-marker-based commercial kit. 展开更多
关键词 Lynch syndrome HNPCC DNA mismatch repair IHC microsatellite instability
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部